Hamza Khan

Hamza Khan is an experienced professional in the field of oncology clinical development, currently serving as the Oncology Clinical Development Associate Director at GSK since March 2023. Prior to this role, Hamza held various positions at Merck from September 2018 to March 2023, including Senior Clinical Scientist and Senior Oncology Clinical Site Manager. Earlier experience includes working as an Oncology Clinical Research Associate at Scimega, and as a Clinical Trial Monitor with the Canadian Cancer Trials Group. Hamza holds a Master’s Degree in Neuroscience and a Bachelor of Science (Honors) in Life Sciences, both from Queen's University.